Margins in DCIS: Does Residual Disease Provide an Answer? Monica MorrowKimberly J. Van Zee Breast Oncology 10 May 2016 Pages: 3423 - 3425
Sentinel Lymph Node Biopsy in Breast Cancer Surgery J. Michael Dixon Breast Oncology 22 July 2016 Pages: 3426 - 3428
Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy for Patients with Axillary Metastases: Can We Avoid the Unavoidable? Theresa SchwartzCarla Fisher Breast Oncology 26 July 2016 Pages: 3429 - 3431
Limiting Axillary Surgery for Patients with Initial Biopsy-Proven Axillary Metastases After Preoperative Chemotherapy: To Clip or Not to Clip? Henry M. KuererKelly K. Hunt Breast Oncology 28 July 2016 Pages: 3432 - 3434
Surgical Breast Specialists 2.0: Rethinking the Future of Breast Fellowship Training Peter D. BeitschPat Whitworth Breast Oncology 22 June 2016 Pages: 3435 - 3437
What Does the Future Hold for Surgical Breast Specialists? Implications for Breast Fellowship Training Scott H. Kurtzman Breast Oncology 24 June 2016 Pages: 3438 - 3439
Guidelines for the Treatment of Recurrent Retroperitoneal Sarcoma: Are we Trying to Fit a Square Peg into a Round Hole? Barry FeigRobert Benjamin Bone and Soft Tissue Sarcomas 22 June 2016 Pages: 3440 - 3443
Association of Distance Traveled for Surgery with Short- and Long-Term Cancer Outcomes Nabil WasifYu-Hui ChangDavid Etzioni Healthcare Policy and Outcomes 28 April 2016 Pages: 3444 - 3452
Should New “No Ink On Tumor” Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins Andrea L. MerrillRong TangBarbara L. Smith Breast Oncology 20 May 2016 Pages: 3453 - 3458
Troubleshooting Sentinel Lymph Node Biopsy in Breast Cancer Surgery Ted A. JamesAlex R. CoffmanSeth P. Harlow Breast Oncology 21 July 2016 Pages: 3459 - 3466
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study Anita MamtaniAndrea V. BarrioMonica Morrow Breast Oncology 09 May 2016 Pages: 3467 - 3474
How Often Is Treatment Effect Identified in Axillary Nodes with a Pathologic Complete Response After Neoadjuvant Chemotherapy? Andrea V. BarrioAnita MamtaniMonica Morrow Breast Oncology 28 July 2016 Pages: 3475 - 3480
Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases Anita MamtaniSujata PatilMonica Morrow Breast Oncology 11 May 2016 Pages: 3481 - 3486
Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma? Melissa PilewskieMichelle StempelMonica Morrow Breast Oncology 12 May 2016 Pages: 3487 - 3493
A Picture is Worth a Thousand Words: Intraoperative Photography as a Quality Metric for Axillary Dissection Brittany L. MurphyJudy C. BougheyJames W. Jakub Breast Oncology 19 May 2016 Pages: 3494 - 3500
Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer Jose VilaElizabeth A. MittendorfAbigail S. Caudle Breast Oncology 23 May 2016 Pages: 3501 - 3509
Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons’ Referrals Eleftherios MamounasChristine PoulosVincent Antao Breast Oncology Open access 09 June 2016 Pages: 3510 - 3517
How Beneficial is Follow-Up Mammography in Elderly Breast Cancer Survivors? Kristen P. MassiminoMaxine S. JochelsonMonica Morrow Breast Oncology 15 June 2016 Pages: 3518 - 3523
Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer Min Chong KimJung Eun ChoiYoung Kyung Bae Breast Oncology 08 June 2016 Pages: 3524 - 3530
Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group Trans-Atlantic RPS Working Group Bone and Soft Tissue Sarcomas 01 August 2016 Pages: 3531 - 3540
Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children’s Oncology Group Najat C. DawNadia N. LaackR. Lor Randall Bone and Soft Tissue Sarcomas 23 May 2016 Pages: 3541 - 3547
National Evaluation of Hospital Performance on the New Commission on Cancer Melanoma Quality Measures Christina A. MinamiJeffrey D. WayneKarl Y. Bilimoria Melanomas 08 June 2016 Pages: 3548 - 3557
LYMPHA Technique to Prevent Secondary Lower Limb Lymphedema Francesco BoccardoMario ValenzanoCorradino Campisi Melanomas 24 May 2016 Pages: 3558 - 3563
Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System Kelly L. HarmsMark A. HealySandra L. Wong Medical Oncology 19 May 2016 Pages: 3564 - 3571
Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma Tobin StromMichael CarrJimmy J. Caudell Radiation Oncology 01 June 2016 Pages: 3572 - 3578
Clinical Impact of Intraoperative Cytological Assessment of Bone Resection Margins in Patients with Head and Neck Carcinoma Markus NieberlerPatrick HäußlerKlaus-Dietrich Wolff Head and Neck Oncology 25 March 2016 Pages: 3579 - 3586
Incidence and Risk Factors for Occult Level 3 Lymph Node Metastases in Papillary Thyroid Cancer Sheila FraserNisar ZaidiStan B. Sidhu Head and Neck Oncology 17 May 2016 Pages: 3587 - 3592
Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study A. J. M. RomboutsN. HugenJ. H. W. de Wilt Colorectal Cancer Open access 01 June 2016 Pages: 3593 - 3601
Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis Dai ShidaTetsuya HamaguchiYukihide Kanemitsu Colorectal Cancer 08 June 2016 Pages: 3602 - 3608
The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer Matthew SuskoJason LeeManisha Palta Radiation Oncology 11 May 2016 Pages: 3609 - 3615
Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry Dainik PatelAmanda R. TownsendTimothy J. Price Thoracic Oncology 01 June 2016 Pages: 3616 - 3622
Value of Percutaneous Radiologic Gastrostomy for Patients with Advanced Esophageal Cancer Keitaro SofueYoshito TakeuchiYasuaki Arai Thoracic Oncology 17 May 2016 Pages: 3623 - 3631
Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis Suun SathornviriyapongAkihisa MatsudaEiji Uchida Thoracic Oncology 08 June 2016 Pages: 3632 - 3640
Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features Brian Hung-Hin LangCarlos K. H. Wong Endocrine Tumors 24 May 2016 Pages: 3641 - 3652
Can We Predict the Lateral Compartment Lymph Node Involvement in RET-Negative Patients with Medullary Thyroid Carcinoma? Marie-Maelle ChandezeSeverine NoulletFabrice Menegaux Endocrine Tumors 06 June 2016 Pages: 3653 - 3659
A Population-Based Analysis of Three Treatment Modalities for Malignant Obstruction of the Proximal Colon: Acute Resection Versus Stent or Stoma as a Bridge to Surgery F. J. AmelungE. C. J. ConstenP. J. Tanis Gastrointestinal Oncology Open access 24 May 2016 Pages: 3660 - 3668
Low Preoperative Prognostic Nutritional Index Predicts Poor Survival Post-gastrectomy in Elderly Patients with Gastric Cancer Katsunobu SakuraiTatsuro TamuraKosei Hirakawa Gastrointestinal Oncology 20 May 2016 Pages: 3669 - 3676
Early Gastric Cancer: Trends in Incidence, Management, and Survival in a Well-Defined French Population Nicolas ChapelleAnne-Marie BouvierValerie Jooste Gastrointestinal Oncology 23 May 2016 Pages: 3677 - 3683
Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis Hyo Jeong KangIn-Seob LeeByung-Sik Kim Gastrointestinal Oncology 24 May 2016 Pages: 3684 - 3692
Hepatic Resection for Metastatic Neuroendocrine Cancer in Patients with Bone Metastases Kristopher P. CroomeJustin M. BurnsDavid M. Nagorney Gastrointestinal Oncology 17 May 2016 Pages: 3693 - 3698
Safety and Feasibility of Repeatable Hepatic Vascular Isolation Chemotherapy: A Pilot Study Rodney J. LaneNyan Y. KhinStephen Clarke Hepatobiliary Tumors 25 March 2016 Pages: 3699 - 3708
Oncological Outcomes of Major Liver Resection Following Portal Vein Embolization: A Systematic Review and Meta-analysis Mariano Cesare GiglioAlexandros GiakoustidisLong R. Jiao Hepatobiliary Tumors 08 June 2016 Pages: 3709 - 3717
Parenchymal-Sparing Hepatectomy Does Not Increase Intrahepatic Recurrence in Patients with Advanced Colorectal Liver Metastases Masaru MatsumuraYoshihiro MiseYu Takahashi Hepatobiliary Tumors 20 May 2016 Pages: 3718 - 3726
A Randomized Clinical Trial of Preoperative Administration of Branched-Chain Amino Acids to Prevent Postoperative Ascites in Patients with Liver Resection for Hepatocellular Carcinoma Yutaro KikuchiYukihiko HiroshimaKuniya Tanaka Hepatobiliary Tumors 23 June 2016 Pages: 3727 - 3735
Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location Kazunari SasakiGeorgios A. MargonisTimothy M. Pawlik Hepatobiliary Tumors 28 June 2016 Pages: 3736 - 3743
Factors Impacting Use of Robotic Surgery for Treatment of Endometrial Cancer in the United States Erin A. BlakeJeanelle SheederMichael S. Guy Gynecologic Oncology 12 May 2016 Pages: 3744 - 3748
Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green Versus Other Conventional Dyes—A Meta-Analysis Ilary RuscitoMaria Luisa GasparriAndrea Papadia Gynecologic Oncology 09 May 2016 Pages: 3749 - 3756
Modified Appleby Procedure for Pancreatic Adenocarcinoma: Does Improved Neoadjuvant Therapy Warrant Such an Aggressive Approach? Niek A. PetersAmmar A. JavedMatthew J. Weiss Pancreatic Tumors 21 June 2016 Pages: 3757 - 3764
Feasibility and Outcomes of the Third or More Episodes of Sequential Microvascular Reconstruction for Recurrent or Second Primary Oral Cancer Anaeze C. Offodile IIKai-Ping ChangHuang-Kai Kao Reconstructive Oncology 20 May 2016 Pages: 3765 - 3772
